Common Kids’ Antibiotic Amoxicillin in Shortage, US FDA Says (1)

Oct. 31, 2022, 3:07 PM UTC

Amoxicillin, an antibiotic commonly used to treat conditions like ear infections and strep throat in children, is in shortage in the US, the Food and Drug Administration said.

Four drugmakers that sell nearly all the amoxicillin in the US have limited supply of some doses of the liquid form of the medicine, which is largely used for kids, the FDA said Friday on its website.

The four suppliers -- Aurobindo Pharma Ltd., Hikma Pharmaceutical Plc, Novartis AG’s Sandoz unit, and Teva Pharmaceutical Industries Ltd. -- sold 99.8% of all liquid amoxicillin prescriptions dispensed at US retail ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.